Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.22.4
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities

The following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they would be anti-dilutive:

 Schedule of Potentially Dilutive Securities

                 
    December 31,  
    2022     2021  
Common stock warrants     2,827,708       2,827,708  
Underwriter warrants     50,416       50,416  
Private warrants     2,059       7,549  
Chanticleer warrants     1,267       1,267  
Series C warrants     809,243       809,243  
Series 3 warrants     276,140        
Unvested restricted stock     220,470       72,425  
Total anti-dilutive weighted average shares     4,187,303       3,768,608